ESC 365 - One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – Discussion.

Open Access

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – Discussion.

Session: The 2020 NSTE - ACS guidelines in practice – the pros and cons

Topic: Acute Coronary Syndromes

Event: ACVC 2021

Congress Presentation

5 more presentations in this session

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - PRO.

Speaker: Professor C. Mueller (Basel, CH)

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - CON.

Speaker: Assistant Professor E. Giannitsis (Heidelberg, DE)

One fits all – high sensitive cardiac troponin is the only marker needed for ACS management - Discussion.

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – PRO.

Speaker: Professor R. Lopes (Durham, US)

One week triple therapy in ACS patients with Atrial fibrillation and PCI as the default strategy – CON.

Speaker: Professor G. Montalescot (Paris, FR)

Access the full session

The 2020 NSTE - ACS guidelines in practice – the pros and cons

Speakers: Professor C. Mueller, Assistant Professor E. Giannitsis, Professor R. Lopes, Professor G. Montalescot

About the event

ACVC 2021

13 March - 14 March 2021

Sessions Presentations

Congress

ESC 365 is supported by